A pre-mixed three-peptide blend (GHK-Cu, TB-500, BPC-157) studied for skin elasticity, collagen synthesis, and tissue regeneration.
GLOW reconstitutes to a set concentration. Add 3.5 mL of bacteriostatic water to a 50 mg vial for a 14.29 mg/mL solution.
| Vial size | BAC water | Concentration | 3.5 mg draws to |
|---|---|---|---|
| 50 mg | 3.5 mL | 14.29 mg/mL | 24.5 units |
| 70 mg | 5 mL | 14 mg/mL | 25 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 3.5 mg. At 14.29 mg/mL, that draws to 24.5 units on a U-100 insulin syringe.
GHK-Cu signals collagen synthesis at the gene level while TB-500 drives cell migration and vascular repair and BPC-157 amplifies soft-tissue healing. The three act across complementary repair pathways.
GLOW is commonly taken morning and evening.
Add 3.5 mL of bacteriostatic water to a 50 mg GLOW vial for a 14.29 mg/mL solution.
A common GLOW starting dose is 3.5 mg, which at 14.29 mg/mL draws to 24.5 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the GLOW vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.
Add 3.5 mL of bacteriostatic water to a 50 mg GLOW vial for a 14.29 mg/mL solution. A 3.5 mg dose then draws to 24.5 units on a U-100 insulin syringe.
Add 5 mL of bacteriostatic water to a 70 mg GLOW vial for a 14 mg/mL solution. A 3.5 mg dose then draws to 25 units on a U-100 insulin syringe.